CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,000 | -25.0% | 1,245 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | 0.0% | 1,245 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -20.0% | 1,245 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | 0.0% | 1,245 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | 0.0% | 1,245 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | -75.0% | 1,245 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $20,000 | +53.8% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $13,000 | -58.1% | 1,245 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $31,000 | -11.4% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $35,000 | +52.2% | 1,245 | 0.0% | 0.00% | +100.0% |
| Q4 2014 | $23,000 | +43.8% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $16,000 | -20.0% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $20,000 | -9.1% | 1,245 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $22,000 | -26.7% | 1,245 | 0.0% | 0.00% | -50.0% |
| Q4 2013 | $30,000 | -31.8% | 1,245 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $44,000 | +131.6% | 1,245 | 0.0% | 0.00% | +200.0% |
| Q2 2013 | $19,000 | – | 1,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |